Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1725665rdf:typepubmed:Citationlld:pubmed
pubmed-article:1725665lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:1725665lifeskim:mentionsumls-concept:C0599953lld:lifeskim
pubmed-article:1725665pubmed:dateCreated1992-5-27lld:pubmed
pubmed-article:1725665pubmed:abstractTextA procedure for the virus inactivation of single donor plasma is described. Virus inactivation is achieved by the combination of 1 mumol of phenothiazin dye, e.g. methylene blue and toluidine blue, and visible light. Using this method VSV, HSV and HIV, as well as other viruses, were inactivated. It could be shown that virus inactivation caused only a minimal reduction in the biological activities of coagulation factors and inhibitors. Furthermore, there was no indication for either neo-antigens or IgE-antibodies. In tolerance studies on dogs it was demonstrated that virus-inactivated autologous plasma caused no toxic effects.lld:pubmed
pubmed-article:1725665pubmed:languagegerlld:pubmed
pubmed-article:1725665pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1725665pubmed:citationSubsetIMlld:pubmed
pubmed-article:1725665pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1725665pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1725665pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1725665pubmed:statusMEDLINElld:pubmed
pubmed-article:1725665pubmed:issn1011-6974lld:pubmed
pubmed-article:1725665pubmed:authorpubmed-author:SchmittHHlld:pubmed
pubmed-article:1725665pubmed:authorpubmed-author:MohrHHlld:pubmed
pubmed-article:1725665pubmed:authorpubmed-author:LambrechtBBlld:pubmed
pubmed-article:1725665pubmed:authorpubmed-author:Knüver-HopfJJlld:pubmed
pubmed-article:1725665pubmed:issnTypePrintlld:pubmed
pubmed-article:1725665pubmed:volume28lld:pubmed
pubmed-article:1725665pubmed:ownerNLMlld:pubmed
pubmed-article:1725665pubmed:authorsCompleteYlld:pubmed
pubmed-article:1725665pubmed:pagination82-91lld:pubmed
pubmed-article:1725665pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1725665pubmed:meshHeadingpubmed-meshheading:1725665-...lld:pubmed
pubmed-article:1725665pubmed:meshHeadingpubmed-meshheading:1725665-...lld:pubmed
pubmed-article:1725665pubmed:meshHeadingpubmed-meshheading:1725665-...lld:pubmed
pubmed-article:1725665pubmed:meshHeadingpubmed-meshheading:1725665-...lld:pubmed
pubmed-article:1725665pubmed:meshHeadingpubmed-meshheading:1725665-...lld:pubmed
pubmed-article:1725665pubmed:meshHeadingpubmed-meshheading:1725665-...lld:pubmed
pubmed-article:1725665pubmed:meshHeadingpubmed-meshheading:1725665-...lld:pubmed
pubmed-article:1725665pubmed:meshHeadingpubmed-meshheading:1725665-...lld:pubmed
pubmed-article:1725665pubmed:meshHeadingpubmed-meshheading:1725665-...lld:pubmed
pubmed-article:1725665pubmed:meshHeadingpubmed-meshheading:1725665-...lld:pubmed
pubmed-article:1725665pubmed:year1991lld:pubmed
pubmed-article:1725665pubmed:articleTitle[Virus inactivation of plasma].lld:pubmed
pubmed-article:1725665pubmed:affiliationZentralinstitut Springe, DRK-Blutspendedienst Niedersachsen, BRD.lld:pubmed
pubmed-article:1725665pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1725665pubmed:publicationTypeEnglish Abstractlld:pubmed